(Q36668229)

15 August 2017

1 reference

title

Hepatocellular cancer in HIV-infected individuals: tomorrow's problem? (English)

1 reference

15 August 2017

main subject

hepatocellular carcinoma

1 reference

Thomas Powles

1

1 reference

15 August 2017

Douglas Macdonald

series ordinal

2

1 reference

15 August 2017

Mark Nelson

series ordinal

3

1 reference

15 August 2017

Justin Stebbing

series ordinal

4

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

11

1 reference

15 August 2017

page(s)

1553-1558

1 reference

The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Epidemiology of AIDS-related malignancies an international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

The growing problem of non-AIDS-defining malignancies in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Hepatocellular carcinoma: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Clinical impact of occult HBV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Occult hepatitis B in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Hepatocellular carcinoma in a patient with human immunodeficiency virus and hepatitis B virus coinfection: an emerging problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Multicenter study of human immunodeficiency virus-related germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Pathology of human immunodeficiency virus infection: noninfectious conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Liver transplantation in HIV-infected recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Treatment of hepatitis C in HIV-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

[Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

Association of Cancer With AIDS-Related Immunosuppression in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.11.1553

10.1586/14737140.6.11.1553

21 January 2018

Identifiers

DOI

1 reference

release_knyhgamzpve3lkzkzrphsvvcke

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/knyhgamzpve3lkzkzrphsvvcke

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference